Article

Chavda, Vivek P ORCID: 0000-0002-7701-8597, Nalla, Lakshmi ORCID: 0000-0002-6077-1099, Balar, Pankti, Bezbaruah, Rajashri, Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771, Singla, Rajeev K ORCID: 0000-0002-3353-7897, Khadela, Avinash ORCID: 0000-0001-9914-8539, Vora, Lalitkumar ORCID: 0000-0001-8106-9066 and Uversky, Vladimir ORCID: 0000-0002-4037-5857 (2023) Advanced phytochemical-based nanocarrier systems for the treatment of breast cancer. Cancers, 15 (4). ISSN 2072-6694

Chavda, Vivek P ORCID: 0000-0002-7701-8597, Patel, Aayushi B, Vora, Lalitkumar, Singla, Rajeev K ORCID: 0000-0002-3353-7897, Shah, Priyal, Uversky, Vladimir N and Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771 (2022) Nitric oxide and its derivatives containing nasal spray and inhalation therapy for the treatment of COVID-19. Current Pharmaceutical Design, 28 (46). pp. 3658-3670. ISSN 1381-6128

Chavda, Vivek P ORCID: 0000-0002-7701-8597, Yao, Qian, Vora, Lalitkumar, Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771, Patel, Chirag A, Bezbaruah, Rajashri, Patel, Aayushi B and Chen, Zhe-Sheng ORCID: 0000-0002-8289-097X (2022) Fast-track development of vaccines for SARS-CoV-2: the shots that saved the world. Frontiers in Immunology, 13. ISSN 1664-3224

Chavda, Vivek P ORCID: 0000-0002-7701-8597, Vora, Lalitkumar and Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771 (2022) Inhalable Vaccines: Can They Help Control Pandemics? Vaccines, 10 (8). pp. 1-5. ISSN 2076-393X

Huang, Zoufang, Chavda, Vivek P ORCID: 0000-0002-7701-8597, Vora, Lalitkumar ORCID: 0000-0001-8106-9066, Gajjar, Normi, Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771, Shah, Nirav and Chen, Zhe-Sheng ORCID: 0000-0002-8289-097X (2022) 2-deoxy-d-glucose and its derivatives for the COVID-19 treatment: an update. Frontiers in Pharmacology, 13. ISSN 1663-9812

Chavda, Vivek P ORCID: 0000-0002-7701-8597, Patel, Aayushi B, Vora, Lalitkumar, Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771 and Uhal, Bruce (2022) Dendritic cell-based vaccine: the state-of-the-art vaccine platform for COVID-19 management. Expert Review of Vaccines, 21 (10). pp. 1395-1403. ISSN 1476-0584